Director of Harch Hyperbaric Oxygen Therapy, treating traumatic brain injury and neurological disorders.
Research in Patrik Brundin’s laboratory of the Van Andel Research Institute focuses on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s disease. The group’s mission is to understand neurodegenerative diseases and develop new therapies that are of benefit to patients and caregivers.
Professor at the Buck Institute for Research on Aging
Director of the Brain Restoration Clinic, and a Board Certified Neurologist with special qualifications in Child Neurology
Director, The Regional MS Center, Center for Neurological Disorders
Aristo Vojdani PhD Environmental Triggers of PANDAS / OCD / ANDAS
Chief Scientific Advisor to Cyrex Laboratories
Marty Hinz MD Compensating for neurotoxin-induced dysregulation
Andrea Gruszecki, ND Environmental exposures and neurotransmitter disruptions- Everyday exposures, oxidative stress and neurodegeneration
Science Support Specialist at Doctor’s Data, Inc
David Steenblock DO
Mark Morningstar DC, PhD NeuroREgeneration: Strategies to Use It, Not Lose It
ICIM member Dr. Morningstar provides comprehensive chiropractic rehabilitation and functional medicine strategies at the Natural Wellness & Pain Relief Center, for complex spine and neurological disorders such as Scoliosis, Fibromyalgia/Chronic Fatigue Syndrome, and Lyme disease.
Boyd Haley PhD An evaluation of heavy metal chelation by various commercially available compounds
ICIM member, and Professor Emeritus in Chemistry/Biochemistry from University of Kentucky. The basic research interest of his laboratory centers on biochemical and biomedical problems involving control at the molecular level.
Debbie Cowden MD Fracking and its role in Neurodegeneration
ICIM member Dr. Cowden is a family medicine doctor in Mount Vernon, Ohio.
Richard Nahas MD Blockages: the missing link in environmental toxicity
Founder of The Seekers Centre, leaders in the emerging field of focusing treatment on the brain.